Novavax COVID vaccine will still save lives, experts say, even with limited supply. There are still more than 26 million American adults who are unvaccinated.

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica was a writer on the Wellness team, with a focus on health ...

Novavax Inc. said Thursday Jan. 28, 2021 that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well ...

LONDON -- American biotechnology company Novavax announced Monday that its experimental COVID-19 vaccine was more than 90% effective against symptomatic disease in late-stage clinical trials ...

Earlier in the pandemic, large studies in the U.S., Mexico and Britain found two doses of the Novavax vaccine were safe and about 90% effective at preventing symptomatic COVID-19.

Vaccine maker Novavax said its COVID-19 shot was highly effective against the disease and also protected against variants in a large study in the U.S. and Mexico.

Novavax vaccines could be available soon after Labor Day, the company said. The Biden administration also plans to restart its free covid-test-by-mail program in late September, allowing Americans ...

Novavax’s recent application for licensing its Covid-19 vaccine in Australia, Canada, and the UK hasn’t gained much traction in the US media. This is odd, given that the vaccine could not only ...

Novavax is new in the covid-fighting arsenal, but it uses the same technology as more established vaccines. Here's how it differs from Pfizer, Moderna and Johnson & Johnson.

Novavax was a covid vaccine underdog. Now it’s in financial trouble. Maryland-based Novavax, which received $1.8 billion from Operation Warp Speed, says it may not continue as a ‘going concern’ ...

This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way.

Novavax Inc. said Thursday Jan. 28, 2021 that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well ...